AMD Update
[ad_1]
A recent article authored by Dr. Ciulla regarding a macular degeneration treatment currently in phase 2 clinical trial…
http://www.visioncareprofessional.com/emails/amdupdate/index.asp?issue=78
Squalamine is a small molecule drug, which has been shown to inhibit multiple angiogenic growth factors including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and basic fibroblast growth factor (bFGF). It does so through a novel intracellular mechanism, which inv…
[ad_2]
Return to main website.